SUBDUE‐3: SUB‐urothelial DUrvalumab‐ <sup>89</sup> zirconium injEction; a phase 0 biodistribution study protocol

Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne

Open source

DOI: 10.1111/bju.70153
Published: 2026-02-11
Container: BJU International
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bju.70153,
  title = {SUBDUE‐3: SUB‐urothelial DUrvalumab‐
                    <sup>89</sup>
                    zirconium injEction; a phase 0 biodistribution study protocol},
  author = {Kevin G. Keane and Richard Gauci and Roslyn J. Francis and Andrew M. Scott and Cynthia Hawks and Andrisha‐Jade Inderjeeth and Ian D. Davis and Jayne Lim and Andrew Redfern and Dickon Hayne},
  year = {2026},
  journal = {BJU International},
  doi = {10.1111/bju.70153},
  url = {https://doi.org/10.1111/bju.70153}
}

RIS

TY  - JOUR
TI  - SUBDUE‐3: SUB‐urothelial DUrvalumab‐
                    <sup>89</sup>
                    zirconium injEction; a phase 0 biodistribution study protocol
AU  - Kevin G. Keane
AU  - Richard Gauci
AU  - Roslyn J. Francis
AU  - Andrew M. Scott
AU  - Cynthia Hawks
AU  - Andrisha‐Jade Inderjeeth
AU  - Ian D. Davis
AU  - Jayne Lim
AU  - Andrew Redfern
AU  - Dickon Hayne
PY  - 2026
JO  - BJU International
DO  - 10.1111/bju.70153
UR  - https://doi.org/10.1111/bju.70153
ER  -

APA

Keane, K. G., Gauci, R., Francis, R. J., Scott, A. M., Hawks, C., Inderjeeth, A., Davis, I. D., Lim, J., Redfern, A., & Hayne, D. (2026). SUBDUE‐3: SUB‐urothelial DUrvalumab‐ <sup>89</sup> zirconium injEction; a phase 0 biodistribution study protocol. BJU International. https://doi.org/10.1111/bju.70153

Source records

crossref · retrieved 2026-09-27T11:44:05.889Z